What's new

Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised

Apr 29, 2025 - 13:27
 0
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Isuzu D-Max pick-up goes electric with full-time 4WD

Next Article

Ligand Engineering of Solution-Processed NiOx for High-Performance n-i-p Perovsk...

Related Posts

EMEA-002493-PIP01-18-M06

EMEA-002493-PIP01-18-M06

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Business process description for paediatric medicines d...

Apr 22, 2025  0